Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PedINDex: Intranasal Dexmedetomidine vs Midazolam for Pediatric Procedural Sedation
NCT03399838Phase 4Withdrawn
- Sponsor
- Insel Gruppe
- Start
- Aug 2023
- Primary completion
- Jul 2024
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of dexmedetomidine in Procedural anxiety, sponsored by Insel Gruppe. Planned start Aug 2023; status: withdrawn.
02
Drugs
dexmedetomidine
03
Conditions
Procedural anxiety
Beyond the preview
Go deeper on NCT03399838.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03399838.